↓ Skip to main content

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind…

Overview of attention for article published in Lancet Infectious Diseases, February 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy
1 policy source
twitter
22 X users
facebook
2 Facebook pages

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
82 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial
Published in
Lancet Infectious Diseases, February 2019
DOI 10.1016/s1473-3099(18)30716-3
Pubmed ID
Authors

Michael Povey, Ouzama Henry, Marianne A Riise Bergsaker, Roman Chlibek, Susanna Esposito, Carl-Erik Flodmark, Leif Gothefors, Sorin Man, Sven-Arne Silfverdal, Mária Štefkovičová, Vytautas Usonis, Jacek Wysocki, Paul Gillard, Roman Prymula

X Demographics

X Demographics

The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 82 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 23%
Student > Bachelor 11 13%
Researcher 8 10%
Other 5 6%
Student > Doctoral Student 4 5%
Other 10 12%
Unknown 25 30%
Readers by discipline Count As %
Medicine and Dentistry 23 28%
Nursing and Health Professions 6 7%
Biochemistry, Genetics and Molecular Biology 3 4%
Agricultural and Biological Sciences 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 9 11%
Unknown 36 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2021.
All research outputs
#2,200,055
of 25,385,509 outputs
Outputs from Lancet Infectious Diseases
#2,362
of 6,039 outputs
Outputs of similar age
#52,971
of 455,881 outputs
Outputs of similar age from Lancet Infectious Diseases
#50
of 125 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,039 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 92.3. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,881 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.